featured
ctDNA to Guide Panitumumab Rechallenge in Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial
Nat. Med. 2022 Aug 01;[EPub Ahead of Print], A Sartore-Bianchi, F Pietrantonio, S Lonardi, B Mussolin, F Rua, G Crisafulli, A Bartolini, E Fenocchio, A Amatu, P Manca, F Bergamo, F Tosi, G Mauri, M Ambrosini, F Daniel, V Torri, A Vanzulli, D Regge, G Cappello, C Marchiò, E Berrino, A Sapino, S Marsoni, S Siena, A BardelliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.